Tirzepatide (Raw Material)

Code Name:C441 CAS No.: 2023788-19-2 Version: V1.0 | For Research Use Only

1. Product Description

Tirzepatide is a synthetic 39‑amino acid peptide that acts as a dual agonist of the glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1) receptors. It is the first approved therapy of its kind for type 2 diabetes mellitus and chronic weight management.

The molecule contains two non‑natural amino acids (Aib, α‑aminoisobutyric acid) which enhance proteolytic stability and prolong plasma half‑life. The C‑terminal amidation and a C20 fatty diacid side chain enable strong albumin binding, allowing for once‑weekly administration.

2. Specifications

3. Physicochemical Properties

4. Storage & Stability

5. Intended Use

• For research into type 2 diabetes mellitus and obesity.

• As an active pharmaceutical ingredient (API) for formulation development.

• For laboratory use only and for export as a raw material. Not for human consumption or direct administration.

6. Additional Notes

• The above specifications are typical for high‑quality research‑grade material. Actual batch‑specific data (e.g., impurity profile, residual solvents) are provided in the Certificate of Analysis (COA) accompanying each shipment.

• Always reconstitute in an appropriate buffer (e.g., sterile water or PBS) immediately before use and store any unused solution at –80°C for short‑term use.

Disclaimer: This TDS is compiled from publicly available information and standard industry practice. It is for informational purposes only and does not constitute a guarantee of any particular batch. Always refer to the actual COA and quality documentation provided by the supplier for the specific material you receive.